Page last updated: 2024-10-26

dimaprit and Leukemia, Promyelocytic, Acute

dimaprit has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seifert, R1
Höer, A1
Schwaner, I1
Buschauer, A1

Other Studies

1 other study available for dimaprit and Leukemia, Promyelocytic, Acute

ArticleYear
Histamine increases cytosolic Ca2+ in HL-60 promyelocytes predominantly via H2 receptors with an unique agonist/antagonist profile and induces functional differentiation.
    Molecular pharmacology, 1992, Volume: 42, Issue:2

    Topics: Adenosine Triphosphate; Calcium; Cations; Cell Differentiation; Cyclic AMP; Cytosol; Dimaprit; Famot

1992